Balentine LLC’s CapForce IBD 50 ETF FFTY Stock Holding History

Balentine LLC’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,833	Closed	-$63K	–	406
2020 Q2	$63K	Buy	+1,833	New	+$56.9K	﹤0.01%	206
2019 Q3	–	Sell	-7,678	Closed	-$263K	–	765
2019 Q2	$263K	Buy	7,678 +800	+12%	+$27K	0.02%	57
2019 Q1	$231K	Buy	+6,878	New	+$216K	0.02%	58

Other funds holding FFTY

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

FAAS

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Balentine LLC's FFTY Position: Q3 2020 in Review

Balentine LLC sold out of CapForce IBD 50 ETF (FFTY) in Q3 2020, closing a stake of 1,833 shares — an estimated $63K sold.

Balentine LLC first reported a position in FFTY in Q1 2019 and held it in 3 quarters. The position peaked at $263K in Q2 2019. 61 funds tracked by Wall St. Rank hold FFTY as of Q3 2020.

Balentine LLC reported no remaining CapForce IBD 50 ETF position as of Q3 2020 after selling out during the quarter.
Balentine LLC sold 1,833 CapForce IBD 50 ETF shares in Q3 2020, an estimated $63K.
Balentine LLC first reported a position in CapForce IBD 50 ETF in Q1 2019 and held it in 3 quarters.
Balentine LLC's CapForce IBD 50 ETF position peaked at $263K in Q2 2019.
61 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.